CVS Caremark (NYSE: CVS) reported earnings on May 1. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), CVS Caremark beat slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue was unchanged. Non-GAAP earnings per share grew significantly. GAAP earnings per share expanded significantly.

Margins grew across the board.

Revenue details
 CVS Caremark reported revenue of $30.76 billion. The 20 analysts polled by S&P Capital IQ expected to see revenue of $30.35 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.83. The 21 earnings estimates compiled by S&P Capital IQ predicted $0.79 per share. Non-GAAP EPS of $0.83 for Q1 were 28% higher than the prior-year quarter's $0.65 per share. GAAP EPS of $0.77 for Q1 were 31% higher than the prior-year quarter's $0.59 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 18.1%, 150 basis points better than the prior-year quarter. Operating margin was 5.5%, 90 basis points better than the prior-year quarter. Net margin was 3.1%, 60 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $31.26 billion. On the bottom line, the average EPS estimate is $0.93.

Next year's average estimate for revenue is $125.29 billion. The average EPS estimate is $3.96.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,701 members out of 1,766 rating the stock outperform, and 65 members rating it underperform. Among 455 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 444 give CVS Caremark a green thumbs-up, and 11 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CVS Caremark is outperform, with an average price target of $58.17.

Is CVS Caremark the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.